EMT6-Luc

PDFを取得

Strain Information

表現型データ

The EMT6-Luc cell line is an EMT6 murine mammary carcinoma cell line derived from a BALB/c mouse with stable and high expression of Luciferase.  Luciferase activity was showed a steady increase in tumor bearing mouse models. The tumorigenesis test showed this cell line could form tumors normally after inoculation in fat pad but no significant lung metastases. Moreover, this cell line metastasize to the liver when they are injected into the spleen. This EMT6-Luc cell line is available for in vivo imaging and assessment of novel therapeutic modalities.

image.png

Figure 1. Morphology of EMT6-Luc cell line.

image.png

Figure 2. Luciferase activity assay of EMT6-Luc cell line.

image.png

Figure 3. (A) Average growth curves of EMT6-Luc tumors. (B) Body weights of EMT6-Luc tumor bearing mice. (n=5) EMT6-Luc cells were inoculated in the fat pads of BALB/C mice.

image.png

Figure 4. In vivo bioluminescence imaging of EMT6-Luc tumor bearing mice. (n=9)

EMT6-Luc cells were inoculated in fat pads of BALB/C mice.

image.png

Figure 5.  In vivo luciferase activity curves of EMT6-Luc lung metastasis. (n=9)

image.png

Figure 6. In vivo bioluminescence imaging of EMT6-Luc lung metastases. (n=9)

image.png

Figure 7.  In vivo luciferase activity curves of EMT6-Luc liver metastasis models. (n=9)

EMT6-Luc cells were intrasplenically injected into BALB/C mice to elicit formation of hepatic metastases.

image.png

Figure 8. In vivo bioluminescence imaging of EMT6-Luc hepatic metastases. (n=9)



関連の系統

あなたも好きかも

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

詳細
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

詳細